The Berkeley Design Review Committee discussed design proposals and conducted final reviews for various city development projects Thursday.
During the meeting, Drew Johnston, vice president of site engineering at Bayer HealthCare LLC’s Berkeley site, discussed a proposal extending the company’s development agreement to February 2052. Additionally, the proposal includes altering various development standards in the agreement to facilitate Bayer’s plans for biopharmaceutical manufacturing facilities.
Johnston explained that in line with sustainability and safety purposes, the development’s plants are native and no illuminated signs will face Aquatic Park.
In response, various committee members expressed concern over the lack of design review in the agreement’s 30-year span.